Mechanical Compliance and Immunological Compatibility of Fixative-Free Decellularized/Cryopreserved Human Pericardium

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Vinci, Maria Cristina ^a   Tessitore, Giulio ^b   Castiglioni, Laura ^b   Prandi, Francesca ^a   Soncini, Monica ^c   Santoro, Rosaria ^a   Consolo, Filippo ^c   Colazzo, Francesca ^b   Micheli, Barbara ^d   Sironi, Luigi ^b   Polvani, Gianluca ^b   Pesce, Maurizio ^a  

^a CENTRO CARDIOLOGICO MONZINO   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c POLITECNICO DI MILANO   (Italy)

^d Banca dei Tessuti Cardiovascolari della Regione Lombardia   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BIOMECHANICS; CELL INVASION; CELL STRUCTURE; CONTROLLED STUDY; CRYOPRESERVATION; DECELLULARIZATION; EXTRACELLULAR MATRIX; HEART TRANSPLANTATION; HUMAN; HUMAN TISSUE; IMMUNITY; IMMUNOCOMPETENT CELL; IMMUNOLOGICAL COMPATIBILITY; INFLAMMATION; PERICARDIUM; TENSILE STRENGTH; TISSUE ENGINEERING;

ANIMALS; COMPLIANCE; CRYOPRESERVATION; FIXATIVES; HUMANS; IMMUNOCOMPETENCE; IMPLANTS, EXPERIMENTAL; MATERIALS TESTING; MICE; PERICARDIUM; STRESS, MECHANICAL; TISSUE ENGINEERING;

EID: 84877962195     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0064769     Document Type: Article

References (37)

1. Carpentier A, Lemaigre G, Robert L, Carpentier S, Dubost C, (1969) Biological factors affecting long-term results of valvular heterografts. J Thorac Cardiovasc Surg 58: 467-483.
2. Grabenwoger M, Sider J, Fitzal F, Zelenka C, Windberger U, et al. (1996) Impact of glutaraldehyde on calcification of pericardial bio-prosthetic heart valve material. Ann Thorac Surg 62: 772-777.
3. Vincentelli A, Latremouille C, Zegdi R, Shen M, Lajos PS, et al. (1998) Does glutaraldehyde induce calcification of bio-prosthetic tissues? Ann Thorac Surg 66: S255-258.
4. Bloch O, Golde P, Dohmen PM, Posner S, Konertz W, et al. (2011) Immune response in patients receiving a bio-prosthetic heart valve: lack of response with decellularized valves. Tissue Eng Part A 17: 2399-2405.
5. Galili U, (2005) The [alpha]-gal epitope and the anti-Gal antibody in xenotransplantation and in cancer immunotherapy. Immunol Cell Biol 83: 674-686.
6. Konakci KZ, Bohle B, Blumer R, Hoetzenecker W, Roth G, et al. (2005) Alpha-Gal on bioprostheses: xenograft immune response in cardiac surgery. Eur J Clin Invest 35: 17-23.
7. McClure RS, Narayanasamy N, Wiegerinck E, Lipsitz S, Maloney A, et al. (2010) Late Outcomes for Aortic Valve Replacement With the Carpentier-Edwards Pericardial Bioprosthesis: Up to 17-Year Follow-Up in 1,000 Patients. The Annals of Thoracic Surgery 89: 1410-1416.
8. Puvimanasinghe JPA, Takkenberg JJM, Eijkemans MJC, Steyerberg EW, van Herwerden LA, et al. (2005) Prognosis After Aortic Valve Replacement With the Carpentier-Edwards Pericardial Valve: Use of Microsimulation. The Annals of Thoracic Surgery 80: 825-831.
9. Mendoza-Novelo B, Avila EE, Cauich-Rodríguez JV, Jorge-Herrero E, Rojo FJ, et al. (2010) Decellularization of pericardial tissue and its impact on tensile viscoelasticity and glycosaminoglycan content. Acta Biomaterialia 7: 1241-1248.
10. Mirsadraee S, Wilcox HE, Korossis SA, Kearney JN, Watterson KG, et al. (2006) Development and characterization of an acellular human pericardial matrix for tissue engineering. Tissue Eng 12: 763-773.
11. Mirsadraee S, Wilcox HE, Watterson KG, Kearney JN, Hunt J, et al. (2007) Biocompatibility of acellular human pericardium. J Surg Res 143: 407-414.
12. Dainese L, Guarino A, Burba I, Esposito G, Pompilio G, et al. (2012) Heart valve engineering: decellularized aortic homograft seeded with human cardiac stromal cells. J Heart Valve Dis 21: 125-134.
13. Korossis SA, Booth C, Wilcox HE, Watterson KG, Kearney JN, et al. (2002) Tissue engineering of cardiac valve prostheses II: biomechanical characterization of decellularized porcine aortic heart valves. J Heart Valve Dis 11: 463-471.
14. Jorge-Herrero E, Fonseca C, Barge AP, Turnay J, Olmo N, et al. (2010) Biocompatibility and calcification of bovine pericardium employed for the construction of cardiac bioprostheses treated with different chemical crosslink methods. Artif Organs 34: E168-176.
15. Sinha P, Zurakowski D, Susheel Kumar TK, He D, Rossi C, et al. (2012) Effects of glutaraldehyde concentration, pretreatment time, and type of tissue (porcine versus bovine) on postimplantation calcification. The Journal of Thoracic and Cardiovascular Surgery 143: 224-227.
16. Maizato MJS, Pires MD, Canzian M, Higa OZ, Pitombo RNM, et al. (2008) Histological Evaluation of Biocompatibility of Lyophilized Bovine Pericardium Implanted Subcutaneously in Rats. Artificial Organs 32: 268-271.
17. Pompilio G, Polvani G, Piccolo G, Guarino A, Nocco A, et al. (2004) Six-year monitoring of the donor-specific immune response to cryopreserved aortic allograft valves: Implications with valve dysfunction. The Annals of Thoracic Surgery 78: 557-563.
18. Oei FBS, Welters MJP, Knoop CJ, Vaessen LMB, Stegmann APA, et al. (2000) Circulating donor-specific cytotoxic T lymphocytes with high avidity for donor human leukocyte antigens in pediatric and adult cardiac allograft valved conduit recipients. European Journal of Cardio-Thoracic Surgery 18: 466-472.
19. Welters MJP, Oei FBS, Vaessen LMB, Stegmann APA, Bogers AJJC, et al. (2001) Increased numbers of circulating donor-specific T helper lymphocytes after human heart valve transplantation. Clinical & Experimental Immunology 124: 353-358.
20. Koolbergen DR, Hazekamp MG, de Heer E, Bruggemans EF, Huysmans HA, et al. (2002) The pathology of fresh and cryopreserved homograft heart valves: An analysis of forty explanted homograft valves. The Journal of Thoracic and Cardiovascular Surgery 124: 689-697.
21. Manji RA, Zhu LF, Nijjar NK, Rayner DC, Korbutt GS, et al. (2006) Glutaraldehyde-Fixed Bio-prosthetic Heart Valve Conduits Calcify and Fail From Xenograft Rejection. Circulation 114: 318-327.
22. Levy RJ, Schoen FJ, Sherman FS, Nichols J, Hawley MA, et al. (1986) Calcification of subcutaneously implanted type I collagen sponges. Effects of formaldehyde and glutaraldehyde pretreatments. Am J Pathol 122: 71-82.
23. Guldner NW, Bastian F, Weigel Gn, Zimmermann Hr, Maleika M, et al. (2012) Nanocoating with titanium reduces iC3b- and granulocyte-activating immune response against glutaraldehyde-fixed bovine pericardium: A new technique to improve biologic heart valve prosthesis durability? The Journal of Thoracic and Cardiovascular Surgery 143: 1152-1159.
24. Guldner NW, Jasmund I, Zimmermann Hr, Heinlein M, Girndt B, et al. (2009) Detoxification and Endothelialization of Glutaraldehyde-Fixed Bovine Pericardium With Titanium Coating. Circulation 119: 1653-1660.
25. Rodas ACD, Polak R, Hara PH, Lee EI, Pitombo RNM, et al. (2011) Cytotoxicity and Endothelial Cell Adhesion of Lyophilized and Irradiated Bovine Pericardium Modified With Silk Fibroin and Chitosan. Artificial Organs 35: 502-507.
26. Rieder E, Seebacher G, Kasimir M-T, Eichmair E, Winter B, et al. (2005) Tissue Engineering of Heart Valves: decellularized porcine and human valve scaffolds differ importantly in residual potential to attract monocytic cells. Circulation 111: 2792-2797.
27. Gaipa G, Tilenni M, Straino S, Burba I, Zaccagnini G, et al. (2010) GMP-based CD133+ cells isolation maintains progenitor angiogenic properties and enhances standardization in cardiovascular cell therapy. J Cell Mol Med 14: 1619-1634.
28. Creemers P, Brink J, Wainwright H, Moore K, Shephard E, et al. (2002) Evaluation of peripheral blood CD4 and CD8 lymphocyte subsets, CD69 expression and histologic rejection grade as diagnostic markers for the presence of cardiac allograft rejection. Transplant Immunology 10: 285-292.
29. Chen CH, Yeh YC, Wu GJ, Huang YH, Lai WF, et al. (2010) Tracking the rejection and survival of mouse ovarian iso- and allografts in vivo with bioluminescent imaging. Reproduction 140: 105-112.
30. Vesely I, (2005) Heart Valve Tissue Engineering. Circulation Research 97: 743-755.
31. Wong ML, Leach JK, Athanasiou KA, Griffiths LG, (2012) The role of protein solubilization in antigen removal from xenogeneic tissue for heart valve tissue engineering. Biomaterials 32: 8129-8138.
32. Dong X, Wei X, Yi W, Gu C, Kang X, et al. (2009) RGD-modified acellular bovine pericardium as a bio-prosthetic scaffold for tissue engineering. J Mater Sci Mater Med.
33. Tedder ME, Liao J, Weed B, Stabler C, Zhang H, et al. (2009) Stabilized collagen scaffolds for heart valve tissue engineering. Tissue Eng Part A 15: 1257-1268.
34. Barili F, Dainese L, Cheema FH, Dell'Antonio G, Topkara VK, et al. (2007) Rates of cycling cells in cryopreserved valvular homograft: a preliminary study. Artif Organs 31: 152-154.
35. Dainese L, Barili F, Topkara VK, Cheema FH, Formato M, et al. (2006) Effect of cryopreservation techniques on aortic valve glycosaminoglycans. Artif Organs 30: 259-264.
36. Lee JM, Boughner DR, (1985) Mechanical properties of human pericardium. Differences in viscoelastic response when compared with canine pericardium. Circulation Research 57: 475-481.
37. Dahms SE, Piechota HJ, Dahiya R, Lue TF, Tanagho EA, (1998) Composition and biomechanical properties of the bladder acellular matrix graft: comparative analysis in rat, pig and human. Br J Urol 82: 411-419.